Dysregulation of BCL-2 family proteins in blood neoplasm: therapeutic relevance of antineoplastic agent venetoclax
During cellular stress, the master regulators of intrinsic self-death (apoptosis) are BCL-2 family proteins. The BCL-2 family proteins play a key role in apoptosis and are tightly regulated via other BCL-2 family proteins, non-BCL-2 protein suppressors, and epigenetic modifications. As the name impl...
Saved in:
Main Author: | Faris Tayeb (Author) |
---|---|
Format: | Book |
Published: |
Open Exploration Publishing Inc.,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
by: Qiang Cao, et al.
Published: (2023) -
PP 8.9 - 00142 Safety and activity of BCL-2 inhibitor Venetoclax in uninfected rhesus macaques
by: T. Wiche Salinas, et al.
Published: (2022) -
Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia
by: Xiang Zhang, et al.
Published: (2021) -
OP 1.8 - 00204 Romidepsin in combination with the BCL-2 antagonist venetoclax synergistically reduce the size of the HIV reservoir
by: Y. Kim, et al.
Published: (2022) -
Efficacy and Safety of Bcl-2 Inhibitor Venetoclax in Hematological Malignancy: A Systematic Review and Meta-Analysis of Clinical Trials
by: Qingfang Li, et al.
Published: (2019)